Influenza virus vaccine 2023 (quadrivalent - Darwin/Sydney/Michigan/Phuket) 0.5 mL Prefilled Syringe, southern hemisphere
RxNorm 2630657
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2630657 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2023 (quadrivalent - Darwin/Sydney/Michigan/Phuket) 0.5 mL Prefilled Syringe, southern hemisphere.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
0.5 mL influenza A virus A/Darwin/9/2021 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Sydney/5/2021 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 mg/ML Prefilled Syringe
(Atom ID: 12796589)
PSN
Prescribable Name (PSN):
Influenza virus vaccine 2023 (quadrivalent - Darwin/Sydney/Michigan/Phuket) 0.5 mL Prefilled Syringe, southern hemisphere
(Atom ID: 12796916)
SY